Mike came to Recursion with over 25 years of experience in big pharma delivering pre-clinical and clinical milestones across several target classes. Working with world-class discovery groups at Upjohn/Pharmacia/Pfizer, Marion Merrell Dow/Aventis and Eli Lilly, he has advanced projects in Infectious Diseases, Cardiovascular, Metabolic Diseases and Autoimmune therapeutic areas. He is an inventor on numerous patents and has a strong publication record.
Mike's interest in Recursion stems from a long time call to deliver high-value medicines to help others and he believes the novel technology (AI and phenotypic assays) at Recursion, combined with an aggressive medicinal chemistry approach, will create opportunities that up until recently have eluded drug discovery scientists.
Mike earned a Ph.D. in medicinal chemistry from the University of Minnesota. In his free time, Mike enjoys spending time with friends and family, fishing, skiing and exploring the outdoors.